MarketCap
Facebook
X
TelegramAnnual report 2024
added 01-24-2026
Koninklijke Philips N.V. Long Term Debt Current 2011-2026 | PHG
Annual Long Term Debt Current Koninklijke Philips N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 241 M | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 241 M | 241 M | 241 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
41 K | $ 3.01 | -2.9 % | $ 97.7 K |  USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 23.56 | -2.04 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.38 | -6.12 % | $ 1.75 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 39.01 | -0.38 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
838 K | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
173 M | $ 218.94 | -0.24 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
27.4 M | $ 102.48 | 0.18 % | $ 19 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 26.01 | -0.88 % | $ 786 M | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
29.2 M | $ 111.89 | 1.28 % | $ 13.7 B | USA |
 |
DexCom
DXCM
|
21.1 M | $ 73.26 | -1.0 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
5.94 M | $ 20.4 | -1.92 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
172 K | $ 109.94 | -1.94 % | $ 4.34 B | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 10.95 | 6.31 % | $ 311 M | Israel |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
1.87 M | $ 65.82 | -1.3 % | $ 4.55 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
79 M | $ 145.95 | -2.5 % | $ 23.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
99 M | $ 230.03 | -2.31 % | $ 41.7 B | USA |
 |
NeoGenomics
NEO
|
3.38 M | $ 11.85 | -4.44 % | $ 1.5 B | USA |
 |
Charles River Laboratories International
CRL
|
54.2 M | $ 210.0 | -0.83 % | $ 10.8 B | USA |
 |
Medpace Holdings
MEDP
|
23.3 M | $ 583.39 | -1.63 % | $ 18.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
173 M | $ 184.82 | 1.37 % | $ 20.5 B | USA |
|
Biodesix
BDSX
|
719 K | $ 8.94 | -7.45 % | $ 1.16 B | USA |
 |
Personalis
PSNL
|
7.7 M | $ 9.4 | -5.72 % | $ 557 M | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
218 K | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
185 M | $ 269.39 | -0.16 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
29.8 M | $ 1 384.16 | -0.62 % | $ 29.4 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 179.07 | -3.67 % | $ 14.8 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
21.5 M | $ 674.78 | -0.29 % | $ 55.6 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.39 | 0.21 % | $ 5.49 M | USA |